| Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment X Ma, E Bi, Y Lu, P Su, C Huang, L Liu, Q Wang, M Yang, MF Kalady, ... Cell metabolism 30 (1), 143-156. e5, 2019 | 537 | 2019 |
| Th9 cells promote antitumor immune responses in vivo Y Lu, S Hong, H Li, J Park, B Hong, L Wang, Y Zheng, Z Liu, J Xu, J He, ... The Journal of clinical investigation 122 (11), 4160-4171, 2012 | 408 | 2012 |
| CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability X Ma, L Xiao, L Liu, L Ye, P Su, E Bi, Q Wang, M Yang, J Qian, Q Yi Cell metabolism 33 (5), 1001-1012. e5, 2021 | 402 | 2021 |
| Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus–related hepatocellular carcinoma DK Jiang, J Sun, G Cao, Y Liu, D Lin, YZ Gao, WH Ren, XD Long, ... Nature genetics 45 (1), 72-75, 2013 | 341 | 2013 |
| Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug–induced apoptosis Y Zheng, Z Cai, S Wang, X Zhang, J Qian, S Hong, H Li, M Wang, J Yang, ... Blood, The Journal of the American Society of Hematology 114 (17), 3625-3628, 2009 | 328 | 2009 |
| Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004 Y Zhou, H Wang, W Fang, JE Romaguer, Y Zhang, KB Delasalle, L Kwak, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 325 | 2008 |
| Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells H Jiang, W Zhang, P Shang, H Zhang, W Fu, F Ye, T Zeng, H Huang, ... Molecular oncology 8 (2), 297-310, 2014 | 283 | 2014 |
| Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function Y Lee, N Martin-Orozco, P Zheng, J Li, P Zhang, H Tan, HJ Park, M Jeong, ... Cell research 27 (8), 1034-1045, 2017 | 282 | 2017 |
| Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice H Qin, B Lerman, I Sakamaki, G Wei, SC Cha, SS Rao, J Qian, ... Nature medicine 20 (6), 676-681, 2014 | 250 | 2014 |
| Cancer and the microenvironment: myeloma-osteoclast interactions as a model S Yaccoby, MJ Wezeman, A Henderson, M Cottler-Fox, Q Yi, B Barlogie, ... Cancer research 64 (6), 2016-2023, 2004 | 247 | 2004 |
| Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells H Li, S Hong, J Qian, Y Zheng, J Yang, Q Yi Blood, The Journal of the American Society of Hematology 116 (2), 210-217, 2010 | 245 | 2010 |
| Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages P Su, Q Wang, E Bi, X Ma, L Liu, M Yang, J Qian, Q Yi Cancer research 80 (7), 1438-1450, 2020 | 242 | 2020 |
| Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex–restricted, CD8-and … A Österborg, Q Yi, L Henriksson, J Fagerberg, S Bergenbrant, ... Blood, The Journal of the American Society of Hematology 91 (7), 2459-2466, 1998 | 219 | 1998 |
| Tumor lysate–specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy YJ Wen, R Min, G Tricot, B Barlogie, Q Yi Blood, The Journal of the American Society of Hematology 99 (9), 3280-3285, 2002 | 183 | 2002 |
| Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo L Zhang, Z Qian, Z Cai, L Sun, H Wang, JB Bartlett, Q Yi, M Wang American journal of hematology 84 (9), 553-559, 2009 | 161 | 2009 |
| Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells YJ Wen, B Barlogie, Q Yi Blood, The Journal of the American Society of Hematology 97 (6), 1750-1755, 2001 | 155 | 2001 |
| Th9 cells represent a unique subset of CD4+ T cells endowed with the ability to eradicate advanced tumors Y Lu, Q Wang, G Xue, E Bi, X Ma, A Wang, J Qian, C Dong, Q Yi Cancer cell 33 (6), 1048-1060. e7, 2018 | 153 | 2018 |
| PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma Y Zheng, J Yang, J Qian, P Qiu, S Hanabuchi, Y Lu, Z Wang, Z Liu, H Li, ... Leukemia 27 (3), 702-710, 2013 | 152 | 2013 |
| β2-Microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells J Xie, Y Wang, ME Freeman III, B Barlogie, Q Yi Blood, The Journal of the American Society of Hematology 101 (10), 4005-4012, 2003 | 147 | 2003 |
| Human C-reactive protein binds activating Fcγ receptors and protects myeloma tumor cells from apoptosis J Yang, M Wezeman, X Zhang, P Lin, M Wang, J Qian, B Wan, LW Kwak, ... Cancer cell 12 (3), 252-265, 2007 | 143 | 2007 |
Jing YangHouston Methodist Research InstituteVerified email at houstonmethodist.org
